Abstract
Aim
The aim of this article is to compare the evidence relating to the effectiveness of complementary/alternative medicine (CAM) in palliative cancer care as it existed in 2000 and 2005.
Methods
Our comparison is based on systematic reviews using the same methodology at these two points in time.
Results
The results reveal a buoyant research activity in this sector. Consequently, new evidence for 19 CAM modalities has emerged between 2000 and 2005. For some treatments, the evidence is encouraging but for very few, it is as yet fully convincing.
Conclusion
It follows that further research is warranted, particularly in areas where the data already looks encouraging.
References
Tovey PA, Broom AF, Chatwin J, Ahmad S, Hafeez M (2005) Use of traditional, complementary and allopathic medicines in Pakistan by cancer patients. Rural Remote Health 5(4):447
Goldstein MS, Brown ER, Ballard-Barbash R, Morgenstern H, Bastani R, Lee J et al (2005) The use of complementary and alternative medicine among California adults with and without cancer. Evid Based Complement Altern Med 2:557–565
Lis CG, Cambron JA, Grutsch JF, Granick J, Gupta D (2006) Self-reported quality of life in users and nonusers of dietary supplements in cancer. Support Care Cancer 14:193–199
Ben-Arye E, Bar-Sela G, Frenkel M, Kuten A, Hermoni D (2006) Is a biopsychosocial-spiritual approach relevant to cancer treatment? A study of patients and oncology staff members on issues of complementary medicine and spirituality. Support Care Cancer 14:147–152
Molassiotis A, Scott JA, Kearney N, Pud D, Magri M, Selvekerova S et al (2006) Complementary and alternative medicine use in breast cancer patients in Europe. Support Care Cancer 14:260–267
Lowenthal RM (2005) Public illness: how the community recommended complementary and alternative medicine for a prominent politician with cancer. Med J Aust 183:576–579
Helyer LK, Chin S, Chui BK, Fitzgerald B, Verma S, Rakovitch E et al (2006) The use of complementary and alternative medicines among patients with locally advanced breast cancer—a descriptive study. BMC Cancer 6:39
Trevena J, Reeder A (2005) Perceptions of New Zealand adults about complementary and alternative therapies for cancer treatment. N Z Med J 118:U1787
Baum M, Cassileth BR, Daniel R, Ernst E, Filshie J, Nagel GA et al (2006) The role of complementary and alternative medicine in the management of early breast cancer: recommendations of the European Society of Mastology (EUSOMA). Eur J Cancer 42:1711–1714
Kemper KJ, Gardiner P, Gobble J, Woods C (2006) Expertise about herbs and dietary supplements among diverse health professionals. BMC Complement Altern Med 6:15
Newell S, Sanson-Fisher RW (2000) Australian oncologists’ self-reported knowledge and attitudes about non-traditional therapies used by cancer patients. Med J Aust 172:110–113
Ernst E, Pittler MH, Stevinson C, White AR (2001) The desktop guide to complementary and alternative medicine. Mosby, Edinburgh
Ernst E, Pittler MH, Wider B, Boddy K (2006) The desktop guide to complementary and alternative medicine, 2nd edn. Mosby/Elsevier, Edinburgh
Jadad AR, Moore RA, Carroll D et al (1996) Assessing the quality of reports of randomised clinical trials: is blinding necessary. Control Clin Trials 17:1–12
Wider B, Ernst E (2003) CAM research funding in the UK: surveys of medical charities in 1999 and 2002. Complement Ther Med 11:165–167
Ernst E, Filshie J, Hardy J (2003) Evidence-based complementary medicine for palliative cancer care: does it make sense? Palliat Med 17:704–707
Ernst E, Pittler MH (1997) Alternative therapy bias. Nature 385:480
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ernst, E., Pittler, M.H., Wider, B. et al. Complementary/alternative medicine for supportive cancer care: development of the evidence-base. Support Care Cancer 15, 565–568 (2007). https://doi.org/10.1007/s00520-006-0174-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-006-0174-y